Quick Asked: Elevar Therapeutics Contact Us?
Last update: 03 May, 2024 
107 Views
What does elevar therapeutics do? SALT LAKE CITY, USA., July 8, 2021 — Elevar Therapeutics, Inc. (“Elevar”), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced the expansion of its executive and senior leadershipWhats new at elevar? Elevar Therapeutics announced data from the ANGEL trial, a randomized phase 3 study of rivoceranib (also known as apatinib) plus best supportive care in patients with gastric or gastroesophageal junction cancer who have failed at least 2 prior lines September 20, 2019 SALT LAKE CITY, USA.What are elevar therapeutics drug candidates? It develops two proprietary drug candidates: rivoceranib (Apatinib), a VEGFR-2 inhibitor, which dealing with a variety of solid tumors and a BTK/JAK3 inhibitor with the potential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent. Elevar Therapeutics's latest funding round in July 2018 was reported to be $20 m.What is electelevar therapeutics? Elevar Therapeutics (previously known as LSK BioPharma) is a pharmaceutical company. It specializes in the clinical development of therapies for unmet medical needs in cancer.
Listing Results Elevar Therapeutics Contact Us? Question Answers
Oasmia’s partner Elevar Therapeutics signs licensing
Uppsala, Sweden, December 28, 2020 – Oasmia Pharmaceutical AB, an innovation-focused specialty pharmaceutical company, today announces that its partner Elevar Therapeutics has signed a licensing agreement with Inceptua Group for the commercialization of Apealea® (paclitaxel micellar) in Europe. Apealea is approved by the European regulatory ...
List of 39 Elevar Therapeutics Employees Find Emails
Elevar Therapeutics United States employs 39 employees. Reveal contacts of top Elevar Therapeutics managers and employees.